Maximus Interna. (540401)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹18.32 |
| Market Cap | ₹253.9 Cr |
| P/E Ratio | 14.61 |
| ROCE | 15.59% |
| ROE | 5.6% |
| Dividend Yield | 0% |
| Profit Growth | -29.5% |
| Debt/Equity | — |
| Sales Growth | 17.72% |
| 52-Week Range | ₹8 — ₹18.32 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹2.78 |
Strengths
- ROCE at 15.59% indicates decent operational capital efficiency
- Sales growth of 17.72% shows business expansion
- Low P/E of 14.61 relative to market cap for a trading business
- No explicit debt/equity ratio suggests a possibly debt-light balance sheet
Concerns
- Profit growth declined 29.50% despite revenue growth, indicating margin stress
- P/B of 6.59 versus ROE of 5.60% implies overvaluation for poor returns
- Zero dividend yield provides no income cushion
- Piotroski F-Score of 4/9 signals weak fundamentals
AI Analysis
When I look at Maximus Interna, I see a trading and distribution business that is growing its top line but failing to convert that into shareholder value. Sales are up 17.72%, which sounds encouraging, but profits have fallen 29.50%. That is a red flag that immediately catches my attention. A business should not grow its revenue while earnings shrink — it suggests pricing power is weak, costs are rising, or the company is buying growth at the expense of margins. The latest quarter shows sales of ₹43 Cr and net profit of just ₹2 Cr, a thin margin that reinforces my concern. The market price of ₹18.32 has doubled from its 52-week low of ₹8.00, yet the book value is only ₹2.78. At a P/B of 6.59 and ROE of just 5.60%, I am paying a huge premium for a very modest return on equity. Graham would say that buying such a business requires exceptional growth prospects to justify the price. The ROCE of 15.59% is better, but for a trading company with no moat and D/E not available, I worry about hidden leverage or working capital risks. The Piotroski F-Score of 4 out of 9 points to weak financial health. The PEG ratio of 0.82 is misleading because it uses past or expected growth, yet profit growth is negative. This is not a compounding machine. At best, this is a turnaround candidate, but I see no margin of safety at this price. I would need to see a clear path to margin expansion and profit growth before considering it. Until then, this belongs on the 'too hard' pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer